课题基金 / 基金详情

Role of Novel CD3+CD4-CD8-Cells in Secondary Anti-Leishmania Immunity

Role of Novel CD3+CD4-CD8-Cells in Secondary Anti-Leishmania Immunity
新型 CD3 CD4-CD8 细胞在二次抗利什曼原虫免疫中的作用
批准号:
229609
负责人:
Okwor Ifeoma B
金额:
$7.65万
依托单位:
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-10-01 至 2013-10-01

项目摘要

项目成果

Okwor Ifeoma B的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Leishmaniases are parasitic diseases that affect both humans and animals. It is caused by species of protozoan parasite belonging to the genus Leishmania, and is transmitted by the bite of female Sand files. The disease is endemic in 88 countries and it i
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Semaphorin 3E Regulates both Innate and Adaptive Immune Response in Lipopolysaccharide Induced Sepsis.
  • 批准号:
    368351
  • 项目类别:
  • 资助金额:
    $0.04万
  • 财政年份:
    2017
  • 负责人:
    Okwor Ifeoma B
  • 依托单位: